Patents by Inventor Guoquing Liu

Guoquing Liu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6784162
    Abstract: A single point mutation in the human lipoprotein lipase gene which results in an A→G nucleotide change at codon 291 (nucleotide 1127) of the lipoprotein lipase gene, and a substitution of serine for the normal asparagine in the lipoprotein lipase gene product is seen with increased frequency in patients with coronary artery disease, and is associated with an increased susceptibility to coronary artery disease, including in particular premature atherosclerosis. This is expressed as a diminished catalytic activity of lipoprotein lipase, lower HDL-cholesterol levels and higher triglyceride levels. Thus, susceptibility of a human individual to premature atherosclerosis can be evaluated by: (a) obtaining a sample of DNA from the individual; and (b) evaluating the sample of DNA for the presence of nucleotides encoding a serine residue as amino acid 291 of the lipoprotein lipase gene product. The presence of a serine residue is indicative of increased susceptibility in the patient.
    Type: Grant
    Filed: July 10, 1997
    Date of Patent: August 31, 2004
    Assignee: The University of British Columbia
    Inventors: Michael R. Hayden, Yuanhong Ma, Suzanne Lewis, Guoquing Liu
  • Patent number: 6210959
    Abstract: For avoidance of cell aggregation and damage to the cells as well as for a reduction of the risk of contamination, an apparatus for the cultivation and concentration of non-adherent cells as well as for the co-culture of two different cell species consists of an elongate hollow vessel comprising a resting surface extending in parallel with the longitudinal axis of said vessel for positioning the hollow vessel for cell culture operation, a standing surface provided orthogonally on the longitudinal axis for positioning the hollow vessel for cell-harvesting operation or for the co-culture of two cell species, at least one closable charging and discharging opening formed on the hollow vessel on the section of the latter which is opposite to said standing surface, and a partitioning wall extending inside the hollow vessel from the standing surface thereof, which partly subdivides the interior space of the vessel, with this partitioning wall being formed at least in parts with a liquid-permeable, however cell-imper
    Type: Grant
    Filed: June 2, 1999
    Date of Patent: April 3, 2001
    Assignee: GSF-Forschungszentrum für Umwelt und Gesundheit GmbH
    Inventors: Antal Lodri, Jean-Pierre Kremer, Gilbert Reisbach, Guoquing Liu
  • Patent number: 5658729
    Abstract: A single point mutation in the human lipoprotein lipase gene which results in an A.fwdarw.G nucleotide change at codon 291 (nucleotide 1127) of the lipoprotein lipase gene, and a substitution of serine for the normal asparagine in the lipoprotein lipase gene product is seen with increased frequency in patients with coronary artery disease, and is associated with an increased susceptibility to coronary artery disease, including in particular premature atherosclerosis. This is expressed as a diminished catalytic activity of lipoprotein lipase, lower HDL-cholesterol levels and higher triglyceride levels. Thus, susceptibility of a human individual to premature atherosclerosis and other forms of coronary artery disease can be evaluated byevaluating the sample of DNA for the presence of nucleotides encoding a serine residue as amino acid 291 of the lipoprotein lipase gene product. The presence of a serine residue is indicative of increased susceptibility in the patient.
    Type: Grant
    Filed: October 11, 1994
    Date of Patent: August 19, 1997
    Assignee: The University of British Columbia
    Inventors: Michael R. Hayden, Yuanhong Ma, Suzanne Lewis, Guoquing Liu